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was the primary outcome and Physical Health Component 
Summary score (PHCS) the secondary outcome.  Results: 
This trial population had very low quality of life and symp-
tom scores at entry. There were no differences over 6 months 
in post-treatment MHCS scores between the treated and un-
treated groups. There was a non-significant outcome (p = 
0.11) for healing with PHCS (1.11; 95% CI –0.255 to 2.473 at 6 
months) and a significant effect (p = 0.027) for blinding; pa-
tients who were unblinded became worse during the trial 
(–1.544; 95% CI –2.913 to –0.176). We found no relevant inter-
action for blinding among treated patients in MHCS and 
PHCS. Expectation of treatment and duration of CFS added 
significantly to the model.  Conclusions: In patients with CFS, 
distant healing appears to have no statistically significant ef-
fect on mental and physical health but the expectation of 
improvement did improve outcome. 
 Copyright © 2008 S. Karger AG, Basel 
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 Abstract 
 Background: Distant healing, a form of spiritual healing, is 
widely used for many conditions but little is known about its 
effectiveness.  Methods: In order to evaluate distant healing 
in patients with a stable chronic condition, we randomised 
409 patients with chronic fatigue syndrome (CFS) from 14 
private practices for environmental medicine in Germany 
and Austria in a two by two factorial design to immediate 
versus deferred (waiting for 6 months) distant healing. Half 
the patients were blinded and half knew their treatment al-
location. Patients were treated for 6 months and allocated to 
groups of 3 healers from a pool of 462 healers in 21 Euro-
pean countries with different healing traditions. Change in 
Mental Health Component Summary (MHCS) score (SF-36) 
Published online: February 14, 2008
 Harald Walach, PhD 
 School of Social Sciences and Samueli Institute for Information Biology 
 University of Northampton, Boughton Green Road 
 Northampton NN2 7AL (UK) 
 Tel. +44 1604 892 952, Fax +44 1604 722 067, E-Mail harald.walach@northampton.ac.uk 
 © 2008 S. Karger AG, Basel
0033–3190/08/0773–0158$24.50/0 
 Accessible online at:
www.karger.com/pps 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
 M
ed
izi
n 
Ba
se
l  
   
   
   
   
   
  
13
1.
15
2.
21
1.
61
 - 
10
/2
5/
20
17
 8
:0
5:
28
 A
M
 Effectiveness of Distant Healing for 
Patients with Chronic Fatigue Syndrome  
Psychother Psychosom 2008;77:158–166 159
 Introduction 
 The use of complementary and alternative medicine 
(CAM) is increasing and is strongly associated with belief 
in the effectiveness of mental and spiritual factors  [1, 2] . 
In a US survey, 7% of individuals had tried spiritual heal-
ing  [1] . Spiritual healing is a ‘broad’ therapy and may be 
defined as an intentional therapeutic influence of one or 
more persons upon another individual without utilizing 
known physical means of interventions  [3] . It encompass-
es prayer and healing, either by touch or distantly  [4–11] 
and plays an important role in the traditional healing sys-
tems of Northern Europe, Africa and Asia. Despite its 
widespread use evidence for efficacy is scarce. In system-
atic reviews of randomised controlled trials comparing 
distant healing versus placebo or control treatment the 
results from individual trials were extremely heteroge-
neous. Methodological limitations of included trials pre-
cluded any firm conclusion about the efficacy of distant 
healing and there is clearly a need for more rigorous trials 
 [12, 13] . Since the publication of these systematic reviews, 
three randomized controlled double-blind trials of re-
mote group prayer in intensive coronary care unit patients 
have been published. One trial found an improvement in 
intensive care scores  [14] . The other two, looking at well-
defined clinical endpoints, found no clinical effect  [15, 
16] . A recent study of distant healing in AIDS  [17] was un-
able to reproduce previous positive pilot results  [18] .
 We intentionally chose patients with chronic fatigue 
syndrome (CFS) because available treatment options for 
patients with CFS, such as cognitive behaviour therapy 
 [19] or graded exercise therapy  [20] , are not generally ef-
fective  [21, 22] , or widely available and only used by some 
CFS patients because of their own individual attribution-
al theories about this illness  [23] . As patients with CFS are 
regularly seeking alternative treatments and may fre-
quent healers, this would appear to be a reasonable inter-
vention to evaluate.
 Our goal was to evaluate the effectiveness of distant 
healing for patients with CFS. We also wished to assess 
the effects of expectation without using deception and 
hence provided the healing intervention both with and 
without the patients’ knowledge. As a control condition, 
patients had to wait for the healing intervention, both 
with and without knowing their group assignment. We 
were therefore able to assess the effect of expectation in 
this 2  ! 2 factorial design as it involved two factors: 
‘treatment’ (immediate or deferred treatment) and the 
participants’ ‘knowledge’, i.e. whether they were informed 
about their treatment or not.
 Method 
 Details of the study design have been published elsewhere  [24] . 
The trial was investigator-initiated, conducted according to Good 
Clinical Practice rules and approved by the ethics committee of 
the University Hospital Freiburg (Approval No. 60/2001) .  We re-
port the trial results following the Consolidated Standards of Re-
porting Trials guidelines  [25] .
 Patients 
 Patients included into the trial had to be 18 years of age or 
older and fulfil the Fukuda criteria for chronic fatigue or the Ox-
ford criteria for severe idiopathic CFS  [26] . Patients with other 
chronic conditions or co-morbidity that typically rules out a di-
agnosis of CFS (e.g. cancer, hepatitis, or depression) were exclud-
ed as was pregnancy and patients with a serious or acute illness or 
hospital admission in the 3 months prior to entry. Clinical assess-
ments were conducted by the recruiting physicians, based on their 
clinical evaluation and appropriate laboratory data. Patients were 
recruited between October 2001 and May 2003 from 14 private 
practices in Germany and Austria by doctors that specialised in 
the treatment of CFS and who normally use an environmental 
medical approach for this diagnosis which includes the prescrip-
tion of nutritional supplements and other complementary thera-
pies such as homeopathy and herbal medicine. We recruited the 
majority of patients through an information campaign and cover-
age in national newspapers, radio and TV. We directed patients to 
the trial coordination centre (H.B.) in Freiburg. The trial coordi-
nation centre ascertained potential eligibility by phone and sent 
patients for final check of eligibility and inclusion to one of the 14 
recruitment centres. The informed consent, a case report form 
and the baseline questionnaires were sent to the trial coordination 
centre. Three portrait photographs were taken, sent to the healer 
coordinator (H.Wi.) and following treatment allocation, forward-
ed to the healers. The trial coordination centre forwarded the pa-
tient identification number for randomisation to the trial auditor 
(G.L.) in the UK.
 Interventions 
 The trial followed a two by two factorial design with the fac-
tors ‘blinded versus un-blinded treatment’ and ‘immediate versus 
deferred treatment’. Of the two groups randomised to immediate 
treatment, one group was informed that they were being healed, 
while the other was not. Two further groups were allocated to the 
deferred treatment with distant healing, one of these groups was 
informed that they would have to wait 6 months for treatment, the 
other was not.
 Following randomisation by the trial auditor the identifica-
tion number, the first name, and the portrait pictures of patients 
assigned to distant healing were forwarded to the healer coordi-
nator. Based on a random assignment code, the healer coordina-
tor assigned 3 healers to each incoming patient and forwarded the 
surname and the pictures to the healers. Healers were replaced if 
they lived within 100 km of the patient’s residence to minimise 
the chance of incidental contact. Each patient was treated by 3 
healers to guarantee minimal coverage in case of dropout or inef-
fective distant healing. Patients and treating physicians were free 
to use any additional concomitant treatment during the entire 
trial period.
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 Healers were self-referred or recommended through national 
healing organisations to the healer coordinator. Healers were 
from many different healing traditions and practiced distant 
healing individually or in groups by either prayer or by imagining 
the transmission of ‘healing energy’, ‘light’ or ‘healing power’ to 
patients. They were free to adopt any scheme of healing intensity 
and frequency in accordance with their normal practice.
 Healers had to complete a weekly healing report for the heal-
ing coordinator to document the time, duration and type of dis-
tant healing for each patient. If the report was not sent back in 
time, the healer was contacted by the healer coordinator and non-
compliant healers were replaced. The monitoring centre (A.N.) 
contacted a random sample of 20% of healers by phone and 
checked whether they had complied with the study protocol.
 Our pragmatic selection criteria for healers were: healers had 
to have experience with distant healing and declare that they be-
lieved in its clinical effects. Healers had to confirm to the inves-
tigators that during their other healing practice they did not in-
terfere with conventional medical treatment, did not diagnose 
patients or accept advance payments from patients or encourage 
or indulge in sexual relationships with patients. All healers were 
informed about the nature of the trial and patient inclusion crite-
ria. They were happy to have a patient’s name, picture and diag-
nosis, a procedure in line with their normal healing practice. We 
collected basic sociodemographic data from each healer as well as 
details of their type of healing practice.
 Outcome Measures 
 The predefined primary endpoint of the trial was self-reported 
mental health as measured with the Mental Health Component 
Summary (MHCS) score of the validated German version of the 
general health questionnaire (SF-36)  [27] . The secondary end-
point was self-reported physical health based on the Physical 
Health Component Summary (PHCS) score (SF-36). We used this 
generic quality of life instrument based on our pilot work with 
CFS, although we now know that this questionnaire may have 
limited sensitivity to detect clinical change in this condition  [28] . 
However, it is widely used for assessing generic outcomes in both 
CFS as well as many other chronic conditions  [29] .
 At baseline, we recorded the patients’ demographic character-
istics. We measured depression with the German version of the 
Centre of the Epidemiologic Study of Depression Scale (Allge-
meine Depressions-Skala)  [30] , fatigue with the Fatigue Severity 
Scale  [31] , health beliefs with the Holistic Complementary and 
Alternative Medicine Questionnaire, a questionnaire specifically 
designed to assess beliefs in CAM  [32] , treatment credibility and 
expectations with the Treatment Credibility and Expectancy 
Scale  [33] . This is a validated scale used to assess treatment expec-
tations and credibility in the context of many types of psycho-
logical intervention. We also measured religious beliefs and prac-
tices with single items. The SF-36 was completed at entry into the 
study and 6 months after recruitment. All measures were com-
pleted before randomisation and at the second time point, before 
patients were unblinded, if applicable.
 Randomisation 
 Allocation of patients to the 4 groups was concealed by a com-
puter algorithm generated at the remote randomisation site in 
Iceland (H.T.). The randomisation code was forwarded to the tri-
al auditor in the UK. With the use of a second single randomisa-
tion procedure, this code was converted by the assistant of the 
trial auditor (G.L.) to guarantee the complete blinding of all in-
vestigators. This assistant had no contact with patients or inves-
tigators and was the only person with access to the second code. 
The assistant sent three different standard letters to the patients, 
in accordance with their allocation, containing the level of infor-
mation predefined in the trial protocol and a pre-stamped post-
card with the request to the patient to send it to the monitoring 
centre. The trial auditor notified the monitoring centre about 
each newly recruited patient. The monitoring centre then verified 
that all randomised patients had been notified about their inclu-
sion. If a patient did not report back 2 weeks following the ran-
domisation, the monitoring centre phoned the patient to verify 
that the patient had been included and received the information. 
Two written reminders and a final telephone reminder ensured a 
high return rate of the post-treatment SF-36. Patients allocated to 
blinded distant healing or blinded waiting, the physicians respon-
sible for their care, the healers, and all the investigators, including 
the biostatistician involved in the final analysis, were blind to 
treatment allocation prior to completion of the analysis.
 Data Handling and Monitoring 
 The trial coordination centre was responsible for data verifica-
tion and entry. Staff involved in data handling and entry was blind 
to the treatment allocation of patients. All data were entered via 
content capturing software (Teleform 7.0, Electric Paper, Cardiff, 
UK). All scanned data were double checked visually. At trial com-
pletion, the integrity of the final database was checked by the tri-
al monitor.
 Sample Size 
 In a previous pilot study of distant healing in patients with dif-
ferent chronic conditions  [34] , we found a 10-point difference in 
the SF-36. This difference corresponds to a standardized mean 
difference of d = 0.66 in the sum scale for distant healing against 
a waiting list control. We assumed the effect size in patients with 
CFS would be smaller because of the chronicity and severity of the 
condition, the more rigorous trial design and because we allowed 
for absolutely no contact between healers and patients. Therefore, 
we estimated an effect size of d = 0.40 in the MHCS (SF-36) as our 
primary outcome and an effect size in MHCS of d = 0.20 as sig-
nificant in predicting an interaction for blinded versus unblinded 
treatment. We consider an effect size of d = 0.20 as clinically rel-
evant. Assuming a power of 80% and a dropout rate of 20%, 100 
patients in each arm (400 in total) were needed to detect the pres-
ence of an effect or interaction of d = 0.20  [35] .
 Statistics 
 Data were analysed using intention to treat. MHCS and PHCS 
scores were calculated according to the SF-36 manual. Missing 
data were interpolated according to the SF-36 manual with pre-
treatment measurements being interpolated by grand means and 
by last-value-carried-forward algorithms for missing post-treat-
ment measurements. Differences in post-treatment score values 
between groups were calculated using analyses of covariance fit-
ted by a general linear model with pre-treatment values being in-
cluded as baseline co-variates, as defined in the protocol. Addi-
tional co-variates to enter the model were specified at an investi-
gators meeting after reviewing the analysis of the main group 
effect and prior to breaking the code of the blinded analysis. Apart 
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from the main effects e.g. treatment and patient blinding for the 
intervention, age, gender, treatment credibility and expectations 
of patients, duration and severity of CFS were entered into the 
model. Predictors not contributing to the model with a p value 
 ! 0.05 were then deleted in the final model. All statistical analyses 
were done using MINITAB version 14.
 Post hoc Analysis and Follow-Up 
 Before telling blinded patients which group they had been al-
located to, we asked them whether they thought they had received 
healing during the study. In addition, we sent out a third SF-36 
questionnaire 6 months after the last patients had completed the 
study to evaluate long-term outcome. This meant that for the pa-
tients recruited into the study right at the beginning the follow-up 
time was 18 months. On average, however, follow-up time was 
similar for patients of all groups.
 Results 
 Recruitment of Healers, the Intervention and 
Participant Flow 
 Distant healing was provided by 462 healers from 21 
European countries. Healers had a mean healing experi-
ence of 9.7 years (SD = 7.9), a mean age of 51 (SD = 10.9) 
and were predominantly female (63%). Commonly used 
techniques for healers in their normal practice were lay-
ing-on of hand (73%), healing prayer (52%), healing med-
itation (40%), Reiki (33%) and chakra therapy (32%). The 
majority of healers practiced part-time (48%), 31% prac-
ticed full time, while 21% practiced occasionally. The 
mean duration of distant healing sessions reported in the 
healers’ diaries was 20.14 min (SD = 13.1). Thirty-four 
Non-expert screening
(n > 1,400)
Expert screening
(n = 875)
Randomized
(n = 411)
Excluded (n > 500)
major exclusion criteria
Excluded (n = 464)
Unable to travel (n = 22)
No recruitment centre
close (n = 17)
Not eligible (n = 424)
Consent withdrawn (n = 1)
Allocated to
knowing and no healing
(n = 109)
Allocated to
knowing and healing
(n = 102)
Allocated to
not knowing and no healing
(n = 95)
Allocated to
not knowing and healing
(n = 105)
Lost to
follow-up (n = 2)
No explanation (n = 2)
Lost to
follow-up (n = 6)
Consent
withdrawn (n = 1)
No explanation (n = 5)
Excluded (n = 1)
Inclusion criteria
not fulfilled (n = 1)
Lost to
follow-up (n = 2)
Consent
withdrawn (n = 1)
No explanation (n = 1)
Excluded (n = 1)
Inclusion criteria
not fulfilled (n = 1)
Lost to
follow-up (n = 3)
Consent
withdrawn (n = 2)
No explanation (n = 1)
Analyzed
(n = 105)
Analyzed
(n = 102)
Analyzed
(n = 94)
Analyzed
(n = 108)
 Fig. 1. Study flow with outcome assessment in the EUHEALS trial of distant healing in patients with CFS. 
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healers had to be substituted due to non-adherence to the 
protocol and 31 healers dropped out during the trial be-
cause they withdrew consent, could no longer be reached 
or discontinued their healing practice.
 Over 1,400 patients were screened for inclusion crite-
ria by the study centre and 875 patients were screened at 
the 14 recruiting practices ( fig. 1 ). Of these, 424 individu-
als did not fulfil the inclusion criteria, 22 were unable to 
travel, for 17 patients no recruitment centre was close 
enough, 1 patient withdrew consent shortly after inclu-
sion, and 411 patients were invited and agreed to partici-
pate. Following randomisation, 2 patients did not fulfil 
inclusion criteria leaving 409 patients for evaluation. Of 
these, 13 withdrew from the study or were lost to follow-
up. Two patients did not receive the treatment they ini-
tially were allocated to. We analysed the full intention-to-
treat sample of 409 patients recruited to this trial.
 Primary Outcome 
 All groups were well balanced for relevant baseline 
characteristics ( table 1 ).  Table 2 shows that for each of the 
four groups there were small differences in the post-treat-
ment – pre-treatment MHCS but substantial variation. 
Negative score values indicate higher MHCS before treat-
ment. The analysis of covariance showed no differences 
in post-treatment MHCS between the groups ( table 3 ). 
There was no relevant interaction between those being 
treated and being blinded and those being treated and not 
being blinded for the intervention. The only significant 
predictor was the pre-treatment MHCS which explained 
most of the overall variance of the model (R 2 : 33.7%).
 Secondary Outcome 
 PHCS demonstrated some changes in three of the four 
groups with somewhat less variation than MHCS. Those 
not being treated, and knowing it, showed virtually no 
difference in the PHCS at completion. In the analysis of 
covariance of post-treatment PHCS there was a small and 
non-significant effect from distant healing (1.11; 95% CI 
–0.255 to 2.473; p value = 0.11). There was no interaction 
effect for treatment and blinding (p value = 0.32), but we 
found a mean difference of –1.544 (–2.913 to –0.176) in 
PHCS between the unblinded and blinded groups, indi-
cating that those knowing they were not being treated 
experienced a slightly worse outcome (p value = 0.03) 
compared with all others.  Figure 2 indicates that there is 
little difference in PHCS for the immediately treated 
groups and the groups who were blinded to the fact that 
they were not treated initially. Those who knew that they 
were not being treated scored on average 2.8 units lower 
Table 1. Baseline characteristics of trial participants
Blinded and
distant healing
(n = 105)
Not blinded and
distant healing
(n = 102)
Blinded and no
distant healing
(n = 94)
Not blinded
and no healing
(n = 108)
Age, years 47.5810.7 48.1810.0 46.2810.9 50.4812.8
Female, % 74.3 76.5 76.6 75.0
Education, % with ≥13 years 48 36 55 42
Unemployment, months 36.3838.2 34.8849.6 27.7822.3 28.7827.4
Duration of CFS, years 11.389.4 9.686.7 9.688.6 11.989.9
Severe idiopathic CFS, % 7.6 2.9 4.3 3.7
Fatigue severity scorea 6.280.9 6.180.9 6.181.1 6.081.1
Credibility of distant healing , z-score –0.2282.65 0.0682.60 –0.3383.01 0.4382.53
Expectancy of distant healing, z-score –0.2082.97 0.1982.74 –0.3082.93 0.2782.77
Belief in CAM, subscale belief b 13.984.6 14.385.0 13.484.5 13.484.5
Belief in CAM subscale holistic medicinec 12.683.2 12.883.8 12.383.6 12.583.6
Never visits church, % 34.6 24.7 24.4 23.3
Considers him/herself unreligious, % 12.2 14.4 11.3 16.8
Considers religion as very important, % 20.1 11.8 17.0 20.0
Values are expressed as mean 8 SD unless otherwise indicated.
a Range of fatigue severity score: 1 (low) to 7 (high). 
b Holistic Complementary and Alternative Medicine Questionnaire: range of subscale Belief in CAM 5 (low) to 30 (high). 
c Holistic Complementary and Alternative Medicine Questionnaire: range of subscale Holistic Health Beliefs 6 (low) to 36 (high).
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on PHCS. Besides blinding, the only covariates contrib-
uting significantly to the model and being positively cor-
related to PHCS were pre-treatment PHCS, duration of 
CFS (the longer the disease duration the lower the PHCS) 
and expectancy of benefit from the treatment (the higher 
the expectation the larger the benefit). This model ex-
plained 50.6% of overall variability of PHCS. An analysis 
of variance without covariates yields essentially the same 
results ( fig. 2 ).
 Post hoc Analysis and Follow-Up 
 The analysis of improvement during the trial of blind-
ed patients according to their beliefs on treatment status 
yielded interesting additional insights: improvement in 
the secondary outcome, PHCS, in blinded and treated pa-
tients was d = 0.72 for patients who believed they were 
treated (n = 19), and d = 0.30 for patients who believed 
A
d
ju
st
ed
 m
ea
n
s
35.5
35.0
34.5
34.0
33.5
33.0
No knowledge Knowledge
Healing
No healing
Table 2. Unadjusted mean (8SD) component summary scores for mental and physical health (SF-36) according to treatment status 
and blinding in patients with CFS (n = 409)
MHCS scores (SF-36) PHCS scores (SF-36)
pre-treatment post-treatment change scores pre-treatment post-treatment change scores
Blinded and distant healing 36.67811.45 36.37811.98 –0.2989.54 31.0288.09 34.6989.77 3.6686.83
Not blinded and distant healing 34.88810.46 36.61810.75 1.74810.25 31.7587.94 34.79810.41 3.0487.38
Blinded and no distant healing 37.28810.27 38.44812.01 1.16811.07 31.7888.83 35.08810.01 3.2987.28
Not blinded and no distant healing 35.16811.56 35.97811.56 0.81810.45 32.7189.81 33.4689.68 0.7587.85
Component scores are normalised to a T distribution with a mean of 50.
Table 3. Analysis of covariance for MHCS and PHCS scores in patients with CFS
Coefficient F p value Effect (SE) 95% CI
MHCS (SF-36)
Distant healing –0.22 0.22  0.64 –0.44 (0.93) –4.04 to 3.16
Blinding for treatment 0.04 0.01  0.93 0.08 (0.94) –3.52 to 3.68
Interaction of distant healing and blinding for treatment 0.63 1.81  0.18 1.25 (0.94) 2.35 to 4.86
Covariates
SF-36 MHCS scores at baseline 0.615 207.2  <0.001
PHCS (SF-36)
Distant healing 0.55 2.56 0.111 1.11 (0.69) –0.26 to 2.47
Blinding for treatment –0.77 4.92 0.027 –1.54 (0.70) –2.91 to –0.18
Interaction of distant healing and blinding for treatment 0.35 1.01 0.316 0.70 (0.70) –0.65 to 2.05
Covariates
SF-36 PHCS scores at baseline 0.800 398.2 <0.001
Time since onset of CFS –0.142 12.05 0.001
Expectancy of benefit from distant healing 0.365 8.75 0.003
 Fig. 2. Adjusted PHCS mean scores (SF-36) for patients with im-
mediate versus deferred healing (healing and no healing) and for 
patients with blinding and no blinding for treatment status (no 
knowledge and knowledge) after 6 months. 
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they had not been treated (n = 80). Improvement in PHSC 
in blinded and untreated patients who believed they were 
treated was d = 0.95 (n = 16), and was d = 0.2 (n = 74) for 
patients who believed they had not been treated. For the 
primary outcome, in MHSC we found similar though less 
pronounced trends: improvement in MHSC in blinded 
and treated patients who believed to be treated was d = 
0.34, and in those who believed that they were not treated 
it was d = –0.1. In blinded and untreated patients who 
believed they were treated the improvement in MHCS 
was d = 0.71, and in those who did not believe to be treat-
ed the MHCS deteriorated (d = –0.04).
 Seventy-five percent of all patients responded to the 
follow-up SF-36 questionnaire. In general, physical health 
continued to improve over the follow-up period and was 
a further 2–3 points for PHCS in all groups. MHCS 
showed a more complex pattern and deteriorated 1 point 
in the group that had not been treated and did not know 
this; this group had received their treatment in the fol-
low-up period. The group that was treated without their 
knowledge during the trial reported a further 4 points of 
improvement in the follow-up period. The group that 
went untreated and knew this improved 4 points after the 
trial, when they knew they were being treated. And those 
who had received their treatment knowingly during the 
trial had not much further improvement in the follow-up 
period.
 Discussion 
 Distant healing itself appears to have no significant ef-
fect on mental or physical health in this patient group. 
However, the improvement seen in both treated groups 
and in those blinded and waiting for treatment, of ap-
proximately a third of a standard deviation in PHCS, is 
clinically important when considering the severity and 
chronicity of this illness. The group that knew they were 
waiting for treatment reported no change in their PHCS. 
The change in the two treated and one of the control 
groups appears to be the effect of expectation; all of these 
individuals were either receiving treatment or thought 
that they might. The only group with a stable outcome 
was the one that knew they would not receive immediate 
treatment. This interpretation is supported by our post 
hoc data which show that the 22 patients who believed 
that they had been treated improved considerably. The 
improvement was more than a standard deviation com-
pared to patients who thought they had not been treated 
(measured 12–18 months after initiation of the treat-
ment). This is also consistent with a recent meta-analysis 
of placebo effects in CFS which reports an effect size of 
19.7% improvement from placebo in this condition  [23] . 
However, since these data and the information about 
treatment beliefs are post hoc it is difficult to assess 
whether the individual’s belief was a result of the im-
provement or the cause for it. It is interesting to see that 
the expectation of outcome was evenly distributed across 
groups before the trial ( table 1 ), hence the effect is not due 
to initial bias. Taken together, this suggests that expecta-
tion and belief are powerful factors in improving the clin-
ical status of people with CFS  [36] .
 This study provides no evidence for the clinical effec-
tiveness of distant healing in itself. This observation 
could have a number of explanations. Generic quality of 
life measures could be less responsive to subtle changes 
in quality of life in this population  [37, 38] , and it is a 
shortcoming that no additional outcome measures are 
available. The inclusion of a heterogeneous group of heal-
ers could have diluted a specific treatment effect from a 
small group of effective healers but we found no evidence 
for such an effect in our data. Some authors have sug-
gested that blinding may destroy effects of healing by 
generating uncertainty in patients and healers  [39] . We 
did not find any interaction between blinding and treat-
ment that would support this hypothesis.
 We calculated that we had an 80% power to detect a 
standardized mean difference of d = 0.28 when allowing 
for interaction so we do not believe that our trial was un-
derpowered. We identified MHCS as the primary out-
come, based on our initial pilot study. In retrospect, it 
appears that patients may be more likely to record im-
provement in physical health because of their attribu-
tions of CFS to physical causes. It has been suggested that 
the sceptical beliefs of trial participants and investigators 
might contribute to unsuccessful outcomes in distant 
healing. Scores of health beliefs measured with the Holis-
tic Complementary and Alternative Medicine Question-
naire were in the average range and pre-treatment expec-
tancies measured with the Treatment Credibility and Ex-
pectancy Scale were centred on zero in our patient 
population, suggesting patient equipoise in relation to 
healing. The study investigators’ attitudes towards dis-
tant healing were also recorded and were similarly bal-
anced. We recruited patients with CFS in Germany and 
Austria through a media campaign and specialized clin-
ics. Our sample is therefore likely to be representative of 
people with severe CFS. Healers practised according to 
various traditions and came from all European countries. 
The findings from this trial therefore may be generalis-
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able to patients with CFS in the context of European heal-
ing traditions.
 The negative findings from this trial do not imply that 
a therapeutic relationship and positive therapeutic intent 
do not have beneficial effects for individual patients. We 
suggest that future studies on spiritual healing particu-
larly focus on the healer-patient relationship and the im-
portance of belief as well as investigating the specific 
therapeutic effects using different methodological ap-
proaches such as qualitative research and N-of-1 trials.
 This rigorously designed, randomized controlled and 
partially blinded trial in patients with CFS showed no 
significant effect for distant healing in MHCS (SF36) and 
a small effect in PHCS (SF36) which might be due to pa-
tient expectation. In addition, we found little evidence for 
a blinding/treatment interaction, although those who 
knew they were not being treated recorded poorer out-
comes for the PHCS scores. Our post hoc analysis sug-
gests that the most important clinical effects of distant 
healing may be related to patients’ beliefs about whether 
they received treatment.
 Acknowledgements 
 The authors are indebted to the healers who provided distant 
healing free of charge and to the patients for trial participation. 
The authors thank Jacqueline Canonica for data monitoring and 
verifying the inclusion of patients into the trial; Michael Lacour 
and Eberhard Schwarz for valuable help and advice; Anna Hack 
for her diligent help with the trial logistics; Beatrix Braack-Gün-
ther, Manfred Engel, Inge Erbe, Karl-Rainer Fabig, Peter Ger-
mann, Annamarie Heinicke, Dorothea Höck, Dieter Klein, Chris-
toph Mai, Miriam Mück, Christian Schopper, Susanne Schunder-
Tatzber and Margarete Werringloer for patient recruitment. We 
are grateful for suggestions for improvement of the manuscript to 
Ted Kaptchuk.
 The study was funded by a grant of the European Commis-
sion, Directorate General XII, within the 5th Framework ‘Quality 
of Life and Living Ressources’ grant QG 2000-055, the Bundes-
amt für Wissenschaft und Bildung, Switzerland (Grant BBW No. 
02.0086) and the Samueli Institute. Harald Walach was funded at 
the time of conducting the study by the Samueli Institute. Alain 
Nordmann and Heiner C. Bucher are funded by grants from San-
tésuisse and the Gottfried and Julia Bangerter-Rhyner Founda-
tion. Dr. Lewith’s post is funded by a grant from the Maurice 
 Laing Foundation.
 
 References 
 1 Astin JA: Why patients use alternative med-
icine. Results of a national study. JAMA 
1998; 279: 1548–1553. 
 2 Barnes PM, Powell-Griner E, McFann K, Na-
hin RL: Complementary and alternative 
medicine use among adults: United States, 
2002. Adv Data 2004; 343: 1–19. 
 3 Benor DJ: Spiritual healing: a unifying influ-
ence in complementary therapies. Compl 
Ther Med 1995; 3: 234–238. 
 4 Warkentin R: Creative response to alterna-
tive medicine: clients of a modern Finnish 
healer in a northwestern Ontario city. Qual 
Health Res 2000; 10: 214–224. 
 5 Wiesendanger H: Fernheilen: Neue Hoff-
nung für chronisch Kranke, Bd 1: Die Viel-
falt der Methoden. Schönbrunn, Lea Verlag, 
2004. 
 6 Wiesendanger H: Fernheilen: Neue Hoff-
nung für chronisch Kranke, Bd 2: Fallbei-
spiele, Forschungen, Einwände, Erklärun-
gen. Schönbrunn, Lea Verlag, 2004. 
 7 Wiesendanger H: Fernheilen: Neue Hoff-
nung für chronisch Kranke, Bd 3: Was Pati-
enten bewegt: Infos, Tipps & Warnungen. 
Schönbrunn, Lea Verlag, 2004. 
 8 Haraldsson E: Research on alternative thera-
pies in Iceland; in Johannessen H, Launso L, 
Olesen SG, Staugard F (eds): Studies in Alter-
native Therapies 1: Contributions from the 
Nordic Countries. Kopenhagen, Odense 
University Press, 1994, pp 46–50. 
 9 Haraldsson E: Spiritual healing in Iceland; 
in Johannessen H, Launso L, Olesen SG, 
Staugard F (eds): Studies in Alternative 
Therapies 1: Contributions from the Nordic 
Countries. Kopenhagen, Odense University 
Press, 1994, pp 103–113. 
 10 Al-Krenawi A, Graham JR, Maoz B: The 
healing significance of the Negev’s Bedouin 
Dervish. Soc Sci Med 1996; 43: 13–21. 
 11 Salib E, Youakim S: Spiritual healing in el-
derly psychiatric patients: a case-control 
study in an Egyptian psychiatric hospital. 
Aging Ment Health 2001; 5: 366–370. 
 12 Abbot NC: Healing as a therapy for human 
disease: a systematic review. J Alternative 
Compl Med 2000; 6: 159–169. 
 13 Astin JA, Harkness E, Ernst E: The efficacy 
of ‘distant healing’: a systematic review of 
randomized trials. Ann Intern Med 2000; 
 132: 903–910. 
 14 Harris WS, Gowda M, Kolb JW, Strychacz 
CP, Vacek JL, Jones PG, Forker A, O’Keefe 
JH, McCallister BD: A randomized, con-
trolled trial of the effects of remote, interces-
sory prayer on outcomes in patients admit-
ted to the coronary care unit. Arch Intern 
Med 1999; 159: 2273–2278. 
 15 Aviles JM, Whelan E, Hernke DA, Williams 
BA, Kenny KE, O’Fallon WM, Kopecky SL: 
Intercessory prayer and cardiovascular dis-
ease progression in a coronary care unit pop-
ulation: a randomized controlled trial. Mayo 
Clin Proc 2001; 76: 1192–1198. 
 16 Krucoff MW, Crater SW, Gallup D, Blanken-
ship JC, Cuffe M, Guameri M, Krieger RA, 
Kshettry VR, Morris K, Oz M, Pichard A, 
Sketch MH Jr, Koenig HG, Mark D, Lee KL: 
Music, imagery, touch, and prayer as ad-
juncts to interventional cardiac care: the 
Monitoring and Actualisation of Noetic 
Trainings (MANTRA) II randomised study. 
Lancet 2005; 366: 211–217. 
 17 Astin JA, Stone J, Abrams DI, Moore DH, 
Couey P, Buscemi R, Targ E: The efficacy of 
distant healing for human immunodeficien-
cy virus – results of a randomized trial. Al-
tern Ther Health Med 2006; 12: 36–41. 
 18 Sicher F, Targ E, Moore D, Smith HS: A ran-
domized double-blind study of the effect of 
distant healing in a population with ad-
vanced AIDS. Report of a small scale study. 
West J Med 1998; 169: 356–363. 
 19 Chambers D, Bagnall A-M, Hempel S, Forbes 
C: Interventions for the treatment, manage-
ment and rehabilitation of patients with 
chronic fatigue syndrome/myalgic encepha-
lomyelitis: an updated systematic review. J 
Roy Soc Med 2006; 99: 506–520. 
 20 Rimes KA, Chalder T: Treatments for chron-
ic fatigue syndrome. Occup Med 2005; 55: 
 32–39. 
 21 Bazelmans E, Prins J, Lulofs R, van der Meer 
J, Bleijenberg G: Cognitive behaviour group 
therapy for chronic fatigue syndrome: a non-
randomised waiting list controlled study. 
Psychother Psychosom 2005; 74: 218–224. 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
 M
ed
izi
n 
Ba
se
l  
   
   
   
   
   
  
13
1.
15
2.
21
1.
61
 - 
10
/2
5/
20
17
 8
:0
5:
28
 A
M
 Walach et al.
 
Psychother Psychosom 2008;77:158–166166
 22 Deale A, Husain K, Chalder T, Wessely S: 
Long-term outcome of cognitive behavior 
therapy versus relaxation therapy for chron-
ic fatigue syndrome: a 5-year follow-up 
study. Am J Psychiatr 2001; 158: 2038–2042. 
 23 Cho HJ, Hotopf M, Wessely S: The placebo 
response in the treatment of chronic fatigue 
syndrome: A systematic review and meta-
analysis. Psychosom Med 2005; 67: 301–313. 
 24 Walach H, Bösch H, Haraldsson E, Marx A, 
Tomasson H, Wiesendanger H, Lewith G: 
Efficacy of distant healing – a proposal for a 
four-armed randomized study (EUHEALS). 
Forsch Komplementärmed Klass Naturheil-
kd 2002; 9: 168–176. 
 25 Altman DG, Schulz KF, Moher D, Egger M, 
Davidoff F, Elbourne D, Gotzsche PC, Lang 
T: The revised CONSORT statement for re-
porting randomized trials: explanation and 
elaboration. Ann Intern Med 2001; 134: 663–
694. 
 26 Fukuda K, Strauss SE, Hickie J, Sharpe MC, 
Dobbins JG, Komaroff A: The chronic fa-
tigue syndrome – a comprehensive approach 
to its definition and study. Ann Intern Med 
1994; 121: 953–959. 
 27 Bullinger M, Kirchberger I: Der SF-36 Frage-
bogen zum Gesundheitszustand (SF-36). 
Handbuch für die deutschsprachige Frage-
bogenversion. Göttingen, Hogrefe, 1998. 
 28 Güthlin C, Walach H: MOS-SF 36 – Struc-
tural equation modeling to test the construct 
validity of the second-order factor structure. 
Eur J Assess 2007; 23: 15–23. 
 29 Pardaens K, Haagdorens L, Van Wambeke P, 
Van den Broeck A, Van Houdenhove B: How 
relevant are exercise capacity measures for 
evaluating treatment effects in chronic fa-
tigue syndrome? Results from a prospective, 
multidisciplinary outcome study. Clin Reha-
bil 2006; 20: 56–66. 
 30 Hautzinger M, Bailer M: Allgemeine De-
pressionsskala (ADS). Die deutsche Version 
des CES-D. Weinheim, Beltz, 1991. 
 31 Kleinman L, Zodet MW, Hakim Z, Aledort 
J, Barker C, Chan K, Krupp L, Revicki D: 
Psychometric evaluation of the fatigue se-
verity scale for use in chronic hepatitis C. 
Qual Life Res 2000; 9: 499–508. 
 32 Lewith GT, Hyland ME, Shaw S: Do attitudes 
toward and beliefs about complementary 
medicine affect treatment outcomes? Am J 
Publ Health 2002; 92: 1604–1606. 
 33 Devilly GJ, Borkovec TD: Psychometric 
properties of the credibility/expectancy 
questionnaire. J Behav Ther Exp Psychiatry 
2000; 31: 73–86. 
 34 Wiesendanger H, Werthmüller L, Reuter K, 
Walach H: Chronically ill patients treated by 
spiritual healing improve in quality of life: 
results of a randomized waiting-list con-
trolled study. J Altern Complement Med 
2001; 7: 45–51. 
 35 Cohen J: Statistical Power Analysis for the 
Behavioral Sciences. Hillsdale, Lawrence 
Erlbaum, 1987. 
 36 Sharpe L, Ryan B, Allard S, Sensky T: Testing 
for the integrity of blinding in clinical trials: 
how valid are forced choice paradigms? Psy-
chother Psychosom 2003; 72: 128–131. 
 37 Huber R, Lacour M, Zunder T: Die Ambu-
lanz für Naturheilverfahren und Umwelt-
medizin an der Universitätsklinik Freiburg. 
Zwischenbericht September 1998 bis Sep-
tember 1999; in Albrecht H, Frühwald M 
(Hsg): Jahrbuch der Karl und Veronica 
Carstens-Stiftung. Essen, KVC Verlag, 2000, 
pp 15–35. 
 38 Prins JB, Bleijenberg G, Bazelmans E, Elving 
LD, de Boo TM, Severens JL, van der Wilt GJ, 
Spinhoven P, van der Meer JW: Cognitive be-
haviour therapy for chronic fatigue syn-
drome: a multicentre randomised controlled 
trial. Lancet 2001; 357: 841–847. 
 39 Dossey L: Healing Words: The Power of 
Prayer and the Practice of Medicine. San 
Francisco, Harper, 1993. 
 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
 M
ed
izi
n 
Ba
se
l  
   
   
   
   
   
  
13
1.
15
2.
21
1.
61
 - 
10
/2
5/
20
17
 8
:0
5:
28
 A
M
